Arrhythmias including atrial fibrillation and congenital heart disease in Kleefstra syndrome: a possible epigenetic link.

Publication Year: 2023

DOI:
10.1093/europace/euae003

PMCID:
PMC10803030

PMID:
38195854

Journal Information

Full Title: Europace

Abbreviation: Europace

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Cardiology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflict of interest: S.M.N. reports consulting support from Abbott Inc., UpToDate Inc., LifeSignals Inc., and TDK Inc., intellectual property owned by University of California Regents and Stanford University. P.J.W. is a consultant for EpiEndoAF. N.B. reports speaker fees from Abbott and Zoll. M.V.P. has grant funding support from Apple Inc., consulting support from Biotronik and Boston Scientific, and consulting and equity interest in QALY, Inc. All remaining authors have declared no conflicts of interest or disclosures."

Evidence found in paper:

"Funding A.B. is supported by a Netherlands Organization for Health Research and Development grant (ZonMw grant 10250022110003). M.W., P.G.F., and C.R. are supported in part by the National Institutes of Health Common Fund, through the Office of Strategic Coordination/Office of the NIH Director under award number(s) U01HG010218. J.K. receives funding from the Netherlands Organization for Health Research and Development (ZonMw grant 91718310). S.M.N is supported by grants from National Institutes of Health (R01 HL83359, R01 HL149134, R01 122384). T.K. is supported by Netherlands Organization for Health Research and Development grants (ZonMw 91718310 and 10250022110003 and the Dutch Research Council grants 015.014.036 and 1160.18.320). M.V.P. has grant funding from National Institutes of Health and National Heart, Lung, and Blood Institute."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025